Surrogate Endpoints Mark Rothmann* Minimal Residue Disease Workshop April 18, 2012 *The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food and Drug - Rothmann - Document - PDFSEARCH.IO

First Page	Meta Content
	Surrogate Endpoints Mark Rothmann* Minimal Residue Disease Workshop April 18, 2012 *The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food and Drug Add to Reading List Open Document File Size: 48,49 KB Share Result on Facebook Facility Robert Temple / / MedicalCondition HIV / disease / / Organization U.S. Food and Drug Administration / National Institute of Health / / Person Mark Rothmann / Thomas Fleming / / SocialTag Epidemiology Clinical trials Medical statistics Medical research Medical terms Surrogate endpoint Clinical endpoint Biomarker Imaging biomarker Medicine

Surrogate Endpoints Mark Rothmann* Minimal Residue Disease Workshop April 18, 2012 *The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food and DrugAdd to Reading List